Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation
TIME-CARE
2 other identifiers
observational
500
1 country
3
Brief Summary
Out-of-hospital cardiac arrest (OHCA) affects 275,000 people in Europe every year. In Italy alone, 50,000 people experience OHCA annually, with only 9% surviving. Half of the survivors suffer severe brain damage. Immediate CPR and defibrillation by bystanders before the ambulance arrives can save lives, but often, CPR starts only when the ambulance gets there. Additionally, half of all OHCAs occur when the person is alone, causing delays in recognizing the emergency, calling for help, and starting lifesaving actions. Effective chest compressions and defibrillation are crucial but are often not done correctly or are not customized for each patient. Current guidelines recommend the same approach for everyone, which doesn't consider individual needs. To tackle these issues, we plan to develop artificial intelligence (AI) algorithms, smartphone apps, and new devices. Our main goal is to create tools and technologies to improve the recognition of OHCA and provide timely and effective interventions, ultimately reducing the impact of OHCA and improving survival rates. First, we aim to create an AI algorithm that can predict major cardiovascular events like heart attacks or cardiac arrests minutes, hours, or days before they happen. We will collect data from wearable devices to train and validate this algorithm, helping us identify individuals at risk. By alerting these individuals, they can seek emergency care and receive treatment before a cardiac arrest occurs. We will also work on recognizing OHCA cases from surveillance camera footage when they happen to people who are alone. Second, to increase the rate of CPR and defibrillation before ambulances arrive, we will develop a smartphone app that geolocates and alerts nearby citizens to act as first responders. The app will guide them on how to quickly find a defibrillator and use it. Third, to find the best spots on the chest for compressions and defibrillation, we will study chest scans from CTs and echocardiograms in both elective patients and cardiac arrest victims. This will help us understand the effects of compressing different heart structures and develop a sensor to determine the optimal positions for compressions and defibrillator pads. Our multidisciplinary team of clinicians, researchers, and engineers will conduct experimental, simulation, and observational studies to develop these technologies, evaluate their potential for patents, design a plan for their use, and test their effectiveness in preventing and recognizing OHCA. We believe that by improving each step in the chain of survival-preventing cardiac events, early recognition, timely CPR and defibrillation, and high-quality advanced resuscitation-we can significantly improve treatment times and reduce the global death and disability rates caused by OHCA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2024
CompletedFirst Posted
Study publicly available on registry
August 5, 2024
CompletedStudy Start
First participant enrolled
January 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
August 6, 2025
August 1, 2025
1.5 years
July 31, 2024
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
Hospital discharge (4 weeks for hospital admission)
Study Arms (3)
Wearable device users
Healthy volunteers (every adult individual with no history of cardiovascular events willing to contribute to the project) and patients who experienced major cardiovascular events (i.e., myocardial infarction or cardiac arrest). Both groups must have worn a wearable device or used a smartphone able to collect healthcare data and biosignals.
Patients with cardiac arrest
Adults resuscitated after cardiac arrest or during ongoing cardiopulmonary resuscitation (CPR).
Patients who received a CT scan
Adults who received a chest CT scan for any reasons.
Interventions
Wearable devices that are preferentially Food and Drug Administration (FDA) and/or Conformité Européenne (CE) marked
Chest CT scan, transesophageal echocardiogram (TEE) scans, or chest X ray
Eligibility Criteria
* Healthy volunteers (every adult individual with no history of cardiovascular events willing to contribute to the project) and patients who experienced major cardiovascular events (i.e., myocardial infarction or cardiac arrest). Both groups must have worn a wearable device or used a smartphone able to collect healthcare data and biosignals. * Patients ≥18 years resuscitated after cardiac arrest or during ongoing cardiopulmonary resuscitation (CPR). * Patients ≥ 18 years who received a chest CT scan for any reasons.
You may qualify if:
- Age 18-70 years;
- Being a healthy volunteer (i.e., an individual with no history of cardiovascular events willing to contribute to the project) or a patient (survivors and non-survivors) who experienced major cardiovascular events (i.e., myocardial infarction or cardiac arrest);
- Users of a smartwatch or smartphone that continuously and automatically collect health data;
- Informed consent.
You may not qualify if:
- Impossibility to access/export data;
- User did not wear the wearable device for periods longer than 24 hours;
- User did not wear the wearable device in the 4 weeks preceding the event.
- AIM 1.2 CARDIAC ARREST DETECTION FROM VIDEOS No patient involved.
- AIM 2: TECHNOLOGIES TO INCREASE CPR AND DEFIBRILLATION USE BEFORE AMBULANCE ARRIVAL No patient involved.
- AIM 3: PATIENT-TAILORED RESUSCITATION AIM 3.1: CLINICAL STUDY IN PATIENTS WHO RECEIVED CPR
- Adults (≥ 18 years);
- Patients suffering a non-traumatic cardiac arrest treated with chest compressions (both survivors and non-survivors);
- Received a TEE, chest x-ray, or chest CT scan as the standard clinical assessment following cardiac arrest;
- Informed consent.
- \- Patients with severe thorax/mediastinal deformity.
- AIM 3.2 CLINICAL STUDY IN PATIENTS WHO RECEIVED A CHEST CT SCAN
- Adults (≥ 18 years);
- Received a chest CT scan for any reasons;
- Informed consent.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Università Vita-Salute San Raffaelelead
- IRCCS Ospedale San Raffaelecollaborator
- Politecnico di Milanocollaborator
- Azienda Ospedaliera Universitaria "Luigi Vanvitelli" (AOV)collaborator
- Azienda Ospedaliera Universitaria Federico II (AOU Federico II)collaborator
Study Sites (3)
IRCCS Ospedale San Raffaele
Milan, 20132, Italy
AOU Policlinico Federico II
Napoli, 80100, Italy
Azienda Ospedaliera Universitaria Vanvitelli
Napoli, 80138, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alberto Zangrillo, MD
IRCCS Ospedale San Raffaele
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
July 31, 2024
First Posted
August 5, 2024
Study Start
January 27, 2025
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
August 6, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share